Oncolytics Biotech (ONCY) EBITDA (2025 - 2026)
Oncolytics Biotech (ONCY) EBITDA from Mar 31, 2025 to Mar 31, 2026. The TTM Oncolytics Biotech (ONCY) EBITDA is -$9.26M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Oncolytics Biotech (ONCY) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year | +85.20% |
Annual EBITDA change of Oncolytics Biotech (ONCY)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$9.26M | -67.68% |
| 2025 | -$29M | +12.57% |
| 2024 | -$25M | -8.29% |
| 2023 | -$28M | +11.76% |
| 2022 | -$25M | -5.59% |
| 2021 | -$26M | +16.89% |
| 2020 | -$23M | -32.07% |
| 2019 | -$33M | +94.37% |
| 2018 | -$17M | +9.09% |
| 2017 | -$16M | +3.17% |
| 2016 | -$15M | +10.35% |
| 2015 | -$14M | N/A |
Comparison Oncolytics Biotech (ONCY) five years EBITDA CAGR with competitors
Oncolytics Biotech (ONCY) five years EBITDA CAGR is 1.73%.